Examining the link between serum albumin levels and hepatic encephalopathy severity in chronic liver disease patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the correlation between serum albumin levels and the severity of hepatic encephalopathy (HE) in patients with chronic liver disease. A sample size of 100-150 patients will be evaluated to ensure adequate statistical power, with assessments including Glasgow Coma Scale scores and various laboratory investigations. The study will also consider clinical characteristics such as prior HE episodes, presence of ascites, and other complications related to chronic liver disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patients aged \>18 years.
* Confirmed chronic liver disease (by imaging ,
* liver function tests , and clinical history).
* Diagnosed with hepatic encephalopathy based on clinical criteria.
* Patients able to provide informed consent.

Exclusion Criteria:

* Patients age less than 18 years old
* Acute liver failure.
* Chronic renal failure on dialysis.
* Pregnant women.
* Patients with active malignancy.

Where it's running

• Sohag university hospital
  Sohag, Egypt Recruiting

Study contacts

• Study coordinator: Kerelos L Sweha, Resident
• Email: kerolos_latief_post@med.sohag.edu.eg
• Phone: +201280416877

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS

  A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.

  Recruiting Air Force Military Medical University, China · Xi'an, Shaanxi · NCT07799948

• Fecal transplant plus standard therapy for refractory hepatic encephalopathy after TIPS

  This study tests whether adding fecal microbiota transplantation to usual medicines helps people with recurrent hepatic encephalopathy after TIPS implant.

  Recruiting Early Phase 1 Air Force Military Medical University, China · Xi'an · NCT07683936

• Apixaban plus carvedilol to prevent portal-hypertension complications in cirrhosis

  This will test whether adding apixaban to carvedilol can help prevent variceal bleeding, portal vein thrombosis, and other portal-hypertension complications in adults with Child-Pugh B cirrhosis.

  Recruiting Phase 4 Asian Institute Of Medical Sciences · Hyderābād, Sindh · NCT07521332

• Developing and testing the Liver Cirrhosis Cognitive Decline Scale (LiCCoS)

  This project will test a short questionnaire called LiCCoS to see if it can spot thinking and everyday mental problems in adults with liver cirrhosis.

  Recruiting University of Malaya · Ambāla, Haryana · NCT07418008

• Melatonin to improve sleep and thinking in people with cirrhosis

  This study will try one month of daily melatonin (compared with one month of thiamine) to see if it improves sleep and thinking in adults with cirrhosis and hepatic encephalopathy.

  Recruiting Weill Medical College of Cornell University · New York, New York · NCT07046429

• Using inhaled amikacin to prevent pneumonia in cirrhosis patients on ventilators

  This study is testing if inhaled amikacin can help prevent pneumonia in patients with cirrhosis who are on ventilators.

  Recruiting at 2 sites Phase 4 Asian Institute of Gastroenterology, India · Hyderabad, Telangana and 1 other locations · NCT06808074

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.